Sarepta Therapeutics traded lower on Monday, extending a slide as the company took the unusual step of refusing a Food and ...

These stocks were poised to make moves Monday: Sarepta Therapeutics was down 2.7% in premarket ... to ship Elevidys to the ambulant population,” following a request from the Food and Drug ...

Sarepta has refused to suspend all dosing of its gene therapy for Duchenne muscular dystrophy, Elevidys, defying a clinical ...